Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A methodological development study demonstrating feasibility and technical characterization of a novel in vitro platform, without clinical validation or comparison to clinical outcomes.
This is a post-hoc exploratory machine-learning analysis of observational transcriptomic and immunological data identifying correlates of antibody durability across vaccines, without prospective validation or clinical outcome prediction in a held-out cohort.